Gemstone spectral imaging in differential diagnosis of posterior wall bladder cancer and prostate hyperplasia protruding into the bladder

Li HAO,Ai-lian LIU,He-qing WANG,Ting ZHANG,Jing-hong LIU,Sheng WANG
DOI: https://doi.org/10.13929/j.1003-3289.2013.02.028
2013-01-01
Abstract:Objective: To investigate value of gemstone spectral imaging (GSI) for differential diagnosis of posterior wall bladder cancer from prostate hyperplasia into bladder. Methods: Twenty patients with posterior wall bladder cancers and 21 patients with prostate hyperplasias into the bladder underwent GSI from 40 to 140 keV. ROIs were selected on the center of the lesions and prostate tissue, respectively. The mean CT value of ROI was measured, the spectrum curve was drawn, and the differences were evaluated statistically. Results: At 50-70 ke V, no statistical difference of the mean CT value was found between posterior wall bladder cancer and prostate tissue, while statistical differences were found under the rest keV conditions, which was most obvious at 100 keV (t=-5.776, P=0.002). There was no statistical difference between prostate and prostate hyperplasia into the bladder. No statistical difference of the mean CT value between posterior wall bladder cancer and prostate hyperplasia was found at 60-90 ke V, while statistical differences were found under the rest keV conditions, which was most obvious at 40 keV (t=-4.711, P=0.001). The slope of energy spectrum curve of posterior wall bladder cancer (k=0.86) was significantly greater than that of prostate hyperplasia into the bladder (k=0.25). Conclusion: GSI can differentiate posterior wall bladder cancer from prostate hyperplasia into the bladder with high accuracy. Copyright © 2013 by the Press of Chinese Journal of Medical Imaging Technology.
What problem does this paper attempt to address?